A stem cell transplant is just the beginning of a patient’s journey towards recovery. After they leave hospital, they can face a huge range of challenges. In this video we speak with Amelia Chong to explore Anthony Nolans, ‘Who Cares?’ campaign which is calling for an urgent review of the care that patients receive after a stem cell transplant.
Browsing: Taxonomy > Biological and targeted therapies
In this editorial find out about the promises and limitations of gemcitabine monotherapy as an adjuvant chemotherapy in pancreatic adenocarcinoma.
Researchers at Sanford Burnham Prebys Medical Discovery Institute (CA, USA) have published a study shedding new light on how the anti-cancer agent K-80003 (TX803) inhibits cancer cell growth.
A study has indicated that patients with advanced inoperable stage 3 lung cancer can benefit from an improved rate of survival when undergoing concurrent chemotherapy and proton therapy.
Arndt Vogel (Hanover Medical University, Germany) provides insight on the recent noninferiority REFLECT trial with lenvatinib vs sorafenib in unresectable hepatocellular carcinoma.
A recent study lead by researchers at Massachusetts General Hospital (MA, USA) has highlighted a novel mechanism behind resistance to angiogenesis inhibitors.
Listen to our exclusive interview with Philip A Philip to find out about novel agents and strategies on the horizon for pancreatic cancer.
In this article, the authors provide an up-to-date review of all reported genomic aberrations in the eight most common pediatric solid tumors with whole-exome sequencing or whole-genome sequencing data.